Key result
The 2018 ESC/ESH guidelines for hypertension management introduce novel and controversial aspects that will influence physicians' management of hypertension in Europe.
This article highlights novel and controversial aspects of the 2018 ESC/ESH hypertension guidelines and discusses their implications for clinical practice in Europe.
Hypertension continues to be the most common preventable cardiovascular risk factor in Europe. Blood pressure (BP) control in the continent remains largely unsatisfactory. For this reason, development of new guidelines has appeared timely and appropriate. In this article, we highlight the novel or controversial aspects of 2018 European Society of Cardiology/European Society of Hypertension (ESC/ESH) guidelines and discuss how they will influence physicians’ management of hypertension in Europe.
No takes yet. Share an insight, caveat, or question.
Volpe et al. (2019) conducted a review in Hypertension. 2018 ESC/ESH guidelines for hypertension management was evaluated. The 2018 ESC/ESH guidelines for hypertension management introduce novel and controversial aspects that will influence physicians' management of hypertension in Europe.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: